Facebook Twitter LinkedIn Google Plus RSS

Zoetis joint venture in China announces first vaccine approval

By ,

Zoetis Inc., the Florham-Park based animal health business that recently spun off from Pfizer Inc., has received the first vaccine approval for its Chinese joint venture.

The company has announced its vaccine for highly pathogenic porcine reproductive and respiratory syndrome was approved by the Ministry of Agriculture.

According to the announcement, Rui Lan An, which will be launched later this month, is the first vaccine to emerge from the joint venture that was established to develop and manufacture animal vaccines specifically designed to answer the needs of China's livestock producers. It will help China's pork producers meet increasing demand in China for pork.

More From This Industry

Write to the Editorial Department at editorial@njbiz.com

Related Stories

Leave a Comment


Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy